Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 249 of 6351
-
Stem cells from umbilical cords may reduce scars after skin grafts
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and effectiveness of human umbilical cord mesenchymal stem cell (hUCMSC) therapy in patients undergoing medium-thickness skin grafts for donor site wounds. The study aims to answer the following main questions: * Question…
Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
A second chance: new tests aim to catch hidden heart damage in childhood cancer survivors
Diagnosis CompletedAnthracyclines treat up to 60% of childhood malignancies with remarkable improvements survival rates. Unfortunately anthracyclines are associated with an increased cardiomyopathy risk. One study showed an almost six-fold greater risk of developing cardiomyopathy compared to sibli…
Sponsor: Queen's University, Belfast • Aim: Diagnosis
Last updated Aug 14, 2026 00:00 UTC
-
Immunotherapy duo shows promise in stopping melanoma return
Disease control Stopped earlyThe purpose of this study is to assess nivolumab plus relatlimab fixed-dose combination (FDC) versus nivolumab alone in participants with completely resected stage III-IV melanoma.
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can a targeted magnetic pulse rewire the depressed brain?
Disease control OngoingThis trial compares intermittent theta-burst stimulation (iTBS) to low frequency repetitive transcranial magnetic stimulation (LFR) in regards to depression and anxiety outcomes in 100 patients with treatment resistant depression (TRD).
Sponsor: University of British Columbia • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New CML pill shows promise in Head-to-Head trial against standard treatments
Disease control OngoingThe study is designed to compare the efficacy of asciminib 80 mg QD versus Investigator selected Tyrosine Kinase Inhibitor (TKI) for the treatment of newly diagnosed, previously untreated patients with Ph+ CML-CP. The Investigator selected TKI will be one of the following treatme…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a Contrast-Enhanced mammogram spot hidden breast cancers?
Diagnosis CompletedWomen taking part in the National Mammography Screening Program, examined at Södersjukhuset Breast Centre at Södra station in Stockholm and recalled because of suspicion of breast cancer will be invited to participate. A Contrast Enhanced Mammography will be added to the standard…
Sponsor: Karolinska Institutet • Aim: Diagnosis
Last updated Aug 28, 2026 00:00 UTC
-
Can an enzyme blocker boost leukemia chemotherapy?
Disease control OngoingCharacterizing the regimen limiting toxicity (RLT) of chemotherapeutic drug Calaspargase Pegol-mknl as remission induction and consolidation chemotherapy in patients with newly diagnosed Acute Myeloid Leukemia (AML) and Identifying the Maximum Tolerated Dose (MTD) and Recommended…
Phase 1 • Sponsor: West Virginia University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a tailored stent graft tame complex aortic aneurysms?
Disease control PausedThe primary objective of this study is to assess the use of a physician-modified Cook Alpha Thoracic Endovascular Graft in the repair of complex aortic aneurysms and thoracoabdominal aortic aneurysms and aneurysms secondary to aortic dissections in high-risk patients having appro…
Sponsor: Medstar Health Research Institute • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a new drug combo shrink Hard-to-Treat salivary gland tumors?
Disease control OngoingThis trial is investigating an intravenous (IV) medication called 9-ING-41 in combination with chemotherapy (carboplatin) for the treatment of advanced salivary gland cancers. The names of the study drug(s) involved in this study are: * 9-ING-41 (a GSK-3β inhibitor) * Carboplat…
Phase 2 • Sponsor: Glenn J. Hanna • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Drug combo before and after surgery could boost liver cancer outcomes
Disease control CompletedThe purpose of this study was to compare the efficacy and safety of camrelizumab + apatinib mesylate neoadjuvant therapy combined with camrelizumab adjuvant therapy and camrelizumab adjuvant therapy alone in patients with technically resectable hepatocellular carcinoma.
Phase 2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Can adding a targeted pill to chemo beat resistant lung cancer?
Disease control OngoingThe study will evaluate the efficacy and safety of treatment with chemotherapy in combination with osimertinib compared to chemotherapy in combination with placebo in patients whose disease has progressed extracranially following first-line osimertinib treatment.
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Can a leukemia drug slow Parkinson's disease?
Disease control OngoingThis is a safety, tolerability, pharmacokinetic and efficacy study in subjects with Parkinson's disease
Phase 2 • Sponsor: Il-Yang Pharm. Co., Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Wearable tech could stop Post-Pregnancy diabetes in its tracks
Prevention OngoingThis study aims to test the following hypotheses in a randomized controlled trial of post-partum women with a history of gestational diabetes mellitus (GDM) that will be followed up for up to 4 years: 1. Post-partum pregnancy is ideal for behavioural modification and adopting a …
Sponsor: KK Women's and Children's Hospital • Aim: Prevention
Last updated Aug 08, 2026 00:03 UTC
-
New drug shows promise for rare lung cancer subtype
Disease control OngoingThe main purpose of the study is to evaluate safety and efficacy of taletrectinib (also known as AB-106 or DS-6051b) monotherapy in the treatment of advanced NSCLC.
Phase 2 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Can a blast of testosterone shrink hard-to-treat prostate cancer?
Disease control Recruiting nowThis study will determine whether the presence of DNA repair deficiency in the form of alterations in the genes ATM, CDK12 or CHEK2 predicts for a high likelihood of responding to the use of intermittent high dose testosterone. This therapy may result in responses in tumors which…
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a new pill calm psoriatic arthritis joint pain?
Disease control OngoingThis study is a phase 3 study,to evaluate the efficacy and safety of different doses of JAK1 inhibitor SHR0302 in subjects with active psoriatic arthritis.
Phase 3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a Blood-Soaked sponge regrow a torn ACL?
Disease control OngoingThis study is designed to evaluate bridge-enhanced ACL restoration (BEAR), a new surgical technique for repairing knees injured by a tear of the anterior cruciate ligament (ACL) that promotes reattachment and healing of the ACL using a blood-enriched implant. BEAR will be compare…
Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a monthly injection protect hearts and kidneys? large trial begins
Disease control CompletedThis study is conducted to see if ziltivekimab reduces the risk of having cardiovascular events (for example heart attack and stroke) in people with cardiovascular disease, chronic kidney disease and inflammation. Participants will either get ziltivekimab (active medicine) or pl…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a pill stop the relentless itch of a liver disease? a major trial aims to find out.
Symptom relief CompletedThis is a 2-part study in PBC participants with cholestatic pruritus and will evaluate the efficacy, safety and impact on health-related quality of life of linerixibat compared with placebo.
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Can AI deliver breast cancer radiation in a single session?
Disease control Recruiting nowThis study aims to evaluate and report the clinical adverse events and dosimetric parameters in breast cancer patients undergoing an "all-in-one (AIO)" one-stop, fully automated radiotherapy workflow. By systematically tracking these clinical and physical metrics, we seek to esta…
Sponsor: Fudan University • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC